Anticoagulation Certificate

Release Date: February 24, 2021
Expiration Date: February 24, 2024
Activity Type: Application-based
CE Credit Hour(s): 32 hours
Activity Fee: $445.00/$545.00 member/non-member

CE Activity Announcement

Overview 

This self-guided, online program will provide 32 hours of ACPE continuing education for pharmacists, incorporating recorded presentations, skill-focused activities, and supportive readings. 

The modules are designed to provide focused education on anticoagulation therapy management, beginning with regulatory drivers and the concept of anticoagulation stewardship; continuing through the medications that comprise anticoagulation therapy and their use in various acute care, ambulatory, and perioperative settings; the unique needs of specialty populations; adverse effect monitoring and management; interpretation of laboratory assays and application to care, and more. Throughout the program, skills needed to be an effective anticoagulation practitioner are discussed. Case studies will be discussed in depth, with practical, real-world situations explored and approaches to treatment explained. Upon completion of all the modules, learners should be proficient in anticoagulation therapy management.

Professional Certificate Requirement 

Once a learner has successfully completed the educational curriculum, he/she will have the opportunity to complete a 75 question comprehensive exam. If the learner successfully completes the exam (minimum 80% passing rate; unlimited attempts permitted), he/she will be eligible to earn the professional certificate.

Listing of the Anticoagulation Certificate Modules

Learning Module

ACPE #

Credit Hours

Introduction to Anticoagulation

0204-0000-21-714-H04-P

2.25

Heparin, Low Molecular Weight Heparin, and Venous Thromboembolism Prophylaxis

0204-0000-21-715-H01-P

2.75

Arterial Disease and Venous Thromboembolism Treatment

0204-0000-21-716-H01-P

2.75

Thrombolytic Therapy

0204-0000-21-717-H01-P

2.25

Warfarin and Focus on the Ambulatory Setting

0204-0000-21-718-H01-P

2.75

Oral Direct Thrombin Inhibitors (DTI), Anti-Xa Agents, and Atrial Fibrillation

0204-0000-21-719-H01-P

2.75

Anticoagulation in Special Populations

0204-0000-21-720-H01-P

3.5

Mechanical Devices and Focus on the Acute Care Setting

0204-0000-21-721-H01-P

2.5

Heparin-Induced Thrombocytopenia: Pathophysiology and Recognition

0204-0000-21-722-H01-P

2.75

Laboratory Assessments

0204-0000-21-723-H01-P

2

Reversing Anticoagulation and Peri-Operative Management

0204-0000-21-724-H01-P

3.5

Skills for Managing Anticoagulation Therapy

0204-0000-21-725-H04-P

2.25